Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01347931 · ClinicalTrials.gov registry record · NA
In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency
A NA study, sponsored by Breathe Technologies.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01347931: Completed NA study, sponsored by Breathe Technologies.
NCT01347931 is a NA study that has completed, run by Breathe Technologies. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01347931, a NA study, has completed, sponsored by Breathe Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The Breathe NIOV™ System will reduce the work of breathing in subjects with chronic respiratory insufficiency who require long-term oxygen therapy (LTOT). The Breathe system will accomplish this by providing oxygen under pressure and augmenting the subject's spontaneous tidal volumes. The combination of efficient oxygen delivery, assisted ventilation, and a comfortable low-profile device, will result in a mean improvement in perceived well-being and ability to perform ADLs, as measured by patient-reported outcome (PRO) instruments.
Primary Outcome
Time in minutes of sustained activity while using test treatments
Interventions
- DEVICE NIOV System
- DEVICE Standard Oxygen Cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01347931 record still lists
NCT01347931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which NIOV System is the first listed.
NCT01347931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01347931 about?
NCT01347931 is a clinical study titled "In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency". The Breathe NIOV™ System will reduce the work of breathing in subjects with chronic respiratory insufficiency who require long-term oxygen therapy (LTOT). The Breathe system will accomplish this by providing oxygen under pressure and augmenting the subject's spontaneous tidal volumes. The combinatio...
What is the current status of trial NCT01347931?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2011-05. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01347931?
The interventions under investigation include: NIOV System (DEVICE), Standard Oxygen Cannula (DEVICE).
Who is sponsoring clinical trial NCT01347931?
This trial is sponsored by Breathe Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01347931's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia